Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma

Figure 4

The prognosis value of BUB1 in HCC patients from the TCGA, GEO, and ICGC cohorts. (a–c) Survival analysis of BUB1 subtypes in HCC from the TGGA (a), ICGC (b), and GSE14520 (c) cohorts. (d, f) Multivariate Cox regression analysis of clinical features and BUB1 expression in TCGA (d) and ICGC (f) cohorts. (e, g) Prognostic nomogram on the basis of clinical features and BUB1 expression in the TCGA (e) and ICGC (g) cohorts.

(a)

(b)

(c)

(d)

(e)

(f)

(g)